These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4092699)

  • 1. Use of the antimicrobial removal device prior to blood culture in patients on antibiotic therapy.
    Ringertz S; Eriksson B; Malmborg AS; Nyström S; Wretlind B
    Eur J Clin Microbiol; 1985 Dec; 4(6):544-7. PubMed ID: 4092699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Antibiotic Removal Device.
    Appleman MD; Swinney RS; Heseltine PN
    J Clin Microbiol; 1982 Feb; 15(2):278-81. PubMed ID: 7068823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of new blood culture processing systems.
    Moody JA; Fasching CE; Shanholtzer CJ; Gerding DN; Peterson LR
    J Clin Microbiol; 1984 Sep; 20(3):351-6. PubMed ID: 6386854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of antibiotic removal by the antibiotic-binding blood culture systems.
    Smith SM; Eng RH
    Diagn Microbiol Infect Dis; 1985 May; 3(3):201-12. PubMed ID: 3888507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of the antibiotic removal device for processing blood cultures.
    de Silva MI; Qadri SM; Hood E
    J Natl Med Assoc; 1986 Sep; 78(9):857-61. PubMed ID: 3097333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid isolation of bacteria from septicemic patients by use of an antimicrobial agent removal device.
    Wallis C; Melnick JL; Wende RD; Riely PE
    J Clin Microbiol; 1980 May; 11(5):462-4. PubMed ID: 6769953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial removal device. A microbiological and clinical evaluation.
    Wright AJ; Thompson RL; McLimans CA; Wilson WR; Washington JA
    Am J Clin Pathol; 1982 Aug; 78(2):173-7. PubMed ID: 7048940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of bacteremia in patients receiving antimicrobial therapy: an evaluation of the antimicrobial removal device and 16B medium.
    Doern GV; Gantz NM
    J Clin Microbiol; 1983 Jul; 18(1):43-8. PubMed ID: 6350353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the antimicrobial removal device].
    Liu YC; Shi FW; Cheng DL; Leu HS
    Taiwan Yi Xue Hui Za Zhi; 1984 Nov; 83(11):1178-9. PubMed ID: 6597284
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia.
    Shitaye D; Asrat D; Woldeamanuel Y; Worku B
    Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the antimicrobial removal device a cost-effective addition to conventional blood cultures?
    Munro R; Collignon PJ; Sorrell TC; Tomlinson P
    J Clin Pathol; 1984 Mar; 37(3):348-51. PubMed ID: 6421896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An evaluation of antimicrobial removal device to isolate bacteria from bacteremic patients with hematological disorders].
    Nakazawa H; Okamoto S; Murase T; Yoshii Y; Aoki I; Toyama K; Ando Y; Uchida H
    Jpn J Antibiot; 1984 Jul; 37(7):1272-8. PubMed ID: 6436553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Microbiologic Characteristics of Early-onset Sepsis Among Very Low Birth Weight Infants: Opportunities for Antibiotic Stewardship.
    Mukhopadhyay S; Puopolo KM
    Pediatr Infect Dis J; 2017 May; 36(5):477-481. PubMed ID: 28403049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved recovery of microorganisms from patients receiving antibiotics with the antimicrobial removal device.
    Peterson LR; Shanholtzer CJ; Mohn ML; Gerding DN
    Am J Clin Pathol; 1983 Nov; 80(5):692-6. PubMed ID: 6356871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of commercial nucleic acid amplification tests in patients with suspected sepsis.
    Ljungström L; Enroth H; Claesson BE; Ovemyr I; Karlsson J; Fröberg B; Brodin AK; Pernestig AK; Jacobsson G; Andersson R; Karlsson D
    BMC Infect Dis; 2015 Apr; 15():199. PubMed ID: 25928122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics.
    Flayhart D; Borek AP; Wakefield T; Dick J; Carroll KC
    J Clin Microbiol; 2007 Mar; 45(3):816-21. PubMed ID: 17166960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An eight-year review of blood culture and susceptibility among sepsis cases in an emergency department in Northeastern Malaysia.
    Hashairi F; Hasan H; Azlan K; Deris ZZ
    Trop Biomed; 2011 Dec; 28(3):599-605. PubMed ID: 22433889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct identification and determination of antimicrobial susceptibility of gram negative bacilli using the PhoenixTM FX system in blood cultures flagging positive].
    Genç Bahçe Y; Toyran A; Aksoy A
    Mikrobiyol Bul; 2019 Apr; 53(2):119-133. PubMed ID: 31130117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.